Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An update from Living Cell Technologies ( (AU:1AI) ) is now available.
Algorae Pharmaceuticals has announced its upcoming Annual General Meeting (AGM) scheduled for October 2, 2025. The meeting will address various agenda items, and shareholders will receive detailed information on participation. This announcement is part of Algorae’s ongoing efforts to engage with stakeholders and maintain transparency in its operations.
More about Living Cell Technologies
Algorae Pharmaceuticals is an AI-enabled pharmaceutical development company focused on discovering and developing synergistic drug combinations for unmet medical needs. Utilizing its proprietary AI platform, AlgoraeOS, the company collaborates with research institutions and pharmaceutical partners to translate AI-predicted therapies into clinical applications. Algorae is publicly traded on the Australian Stock Exchange.
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$10.12M
See more data about 1AI stock on TipRanks’ Stock Analysis page.